Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

14.81
+0.05000.34%
Post-market: 14.810.00000.00%16:49 EST
Volume:162.53K
Turnover:2.40M
Market Cap:397.17M
PE:-57.23
High:14.92
Open:14.83
Low:14.49
Close:14.76
52wk High:23.00
52wk Low:11.09
Shares:26.82M
Float Shares:18.14M
Volume Ratio:0.68
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2588
EPS(LYR):-0.1476
ROE:-34.17%
ROA:1.25%
PB:17.17
PE(LYR):-100.32

Loading ...

Feb 02, 2026

Major Issues Report

Form 8-K - Current report
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 19, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities